ConductScience.org, home

Paper39130445

HDAC6 inhibition as a mechanism to prevent neurodegeneration in the mSOD1G93A mouse model of ALS.

Phipps AJ and 14 others. Heliyon, 2024. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. HDAC6 inhibition as a mechanism to prevent neurodegeneration in the mSOD1G93A mouse model of ALS. Papers, record 39130445. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39130445

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
HDAC6 inhibition as a mechanism to prevent neurodegeneration in the mSOD1G93A mouse model of ALS.
PubMed
Journal
Heliyon
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
1.36, provisional
iCite
Revised in PubMed
2024-08-13
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Phipps AJAndrew J
2Dwyer SSamuel
3Collins JMJessica M
4Kabir FFariha
5Atkinson RARachel Ak
6Chowdhury MAMd Anisuzzaman
7Matthews LLyzette
8Dixit DDeepika
9Terry RSRhiannon S
10Smith JJason
11Gueven NNuri
12Bennett WWilliam
13Cook ALAnthony L
14King AEAnna E
15Perry SSharn

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127957719Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot-Marie-Tooth Disease.Neurotherapeutics2017https://conductscience.org/library/papers/27957719PubMed
230309882Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis.J Neurol Neurosurg Psychiatry2019https://conductscience.org/library/papers/30309882PubMed
324073237Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.PLoS One2013https://conductscience.org/library/papers/24073237PubMed
431705657Microtubule-dependent processes precede pathological calcium influx in excitotoxin-induced axon degeneration.J Neurochem2020https://conductscience.org/library/papers/31705657PubMed
524932665Interplay between HDAC6 and its interacting partners: essential roles in the aggresome-autophagy pathway and neurodegenerative diseases.DNA Cell Biol2014https://conductscience.org/library/papers/24932665PubMed
636705941An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis.Expert Rev Neurother2023https://conductscience.org/library/papers/36705941PubMed
715579172Benefit of valproic acid in suppressing disease progression of ALS model mice.Eur J Neurosci2004https://conductscience.org/library/papers/15579172PubMed
817934327Axonal degeneration in motor neuron disease.Neurodegener Dis2007https://conductscience.org/library/papers/17934327PubMed
932877582Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis.N Engl J Med2020https://conductscience.org/library/papers/32877582PubMed
1021712032Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis.Exp Neurol2011https://conductscience.org/library/papers/21712032PubMed
1126485052A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS.J Vis Exp2015https://conductscience.org/library/papers/26485052PubMed
1223463871Pathophysiological insights into ALS with C9ORF72 expansions.J Neurol Neurosurg Psychiatry2013https://conductscience.org/library/papers/23463871PubMed
1317522299Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model.J Neurosci2007https://conductscience.org/library/papers/17522299PubMed
1430555293The HDAC6 Inhibitor Trichostatin A Acetylates Microtubules and Protects Axons From Excitotoxin-Induced Degeneration in a Compartmented Culture Model.Front Neurosci2018https://conductscience.org/library/papers/30555293PubMed
1515934930Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice.J Neurochem2005https://conductscience.org/library/papers/15934930PubMed
1635354901NU-9 improves health of hSOD1G93A mouse upper motor neurons in vitro, especially in combination with riluzole or edaravone.Sci Rep2022https://conductscience.org/library/papers/35354901PubMed
1711050249Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1.Proc Natl Acad Sci U S A2000https://conductscience.org/library/papers/11050249PubMed
1816167067HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis.Cell Death Differ2006https://conductscience.org/library/papers/16167067PubMed
1921909419Metformin treatment has no beneficial effect in a dose-response survival study in the SOD1(G93A) mouse model of ALS and is harmful in female mice.PLoS One2011https://conductscience.org/library/papers/21909419PubMed
2029054467The multi-dimensional roles of astrocytes in ALS.Neurosci Res2018https://conductscience.org/library/papers/29054467PubMed

See all 61 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42875680Restoring Neural Homeostasis via Class II HDAC Modulation: Mechanistic Insights and Therapeutic Opportunities.Mol Neurobiol2026https://conductscience.org/library/papers/42875680PubMed
42481875The centrosome-cilium-centriolar satellite axis in neurodegenerative diseases.EMBO Rep2026https://conductscience.org/library/papers/42481875PubMed
41378251Molecular and cellular mechanisms of pentadecanoic acid.World J Biol Chem2025https://conductscience.org/library/papers/41378251PubMed
41237781Advances and challenges in modeling Charcot-Marie-Tooth type 2A using iPSC-derived models.Stem Cell Reports2025https://conductscience.org/library/papers/41237781PubMed
41061670A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementia.Brain2026https://conductscience.org/library/papers/41061670PubMed
40641131Histone deacetylase 6: A new player in oxidative stress‑associated disorders and cancers (Review).Int J Mol Med2025https://conductscience.org/library/papers/40641131PubMed
40593212Impact of Histone Acetyltransferases and Histone Deacetylases on Adult Brain Myelin Plasticity.Results Probl Cell Differ2025https://conductscience.org/library/papers/40593212PubMed
40542954Single-Nucleus RNA Sequencing of HDAC6 Inhibition in Resolving Doxorubicin-Induced Cognitive Impairment.Mol Neurobiol2025https://conductscience.org/library/papers/40542954PubMed
40333935Histone Deacetylase 6 Brain PET in Amyotrophic Lateral Sclerosis-Frontotemporal Spectrum Disorder.Ann Clin Transl Neurol2025https://conductscience.org/library/papers/40333935PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39130445

GET https://conductscience.org/api/papers/v1/39130445/references?page=2